No faster decline seen in women 75-plus with early breast cancer
An observational study followed 168 women with breast cancer and 336 without for 12 months, finding no significant differences in decline in daily functioning or thinking skills.
The prospective observational study compared 168 women aged 75 years and older with operable breast cancer with 336 community-dwelling women aged 75 and older without cancer. Participants came from two Dutch cohorts and had a mean age of 80. Researchers matched them on age and initial daily functioning or thinking skills, then analysed changes over 12 months.
Most women with cancer received surgery, radiation therapy or both. Hormone therapy after their main treatment was given to 48%; fewer than 1% received chemotherapy. Analyses both with and without adjustments for other factors found no significant difference in functional or cognitive decline between the groups. The researchers suggested that treatment may not accelerate short-term functional decline in relatively fit older women.
Why it matters
Breast cancer care in older age raises questions about maintaining independence and thinking skills. This study addresses those concerns during the first year after treatment began.
Caveats
This observational comparison cannot establish cause and effect; women without cancer also had more other illnesses at the outset. The preprint has not been peer-reviewed, and its findings may not apply to frailer women or those receiving chemotherapy.
The paper
Leiden University Medical Center
medRxiv, 15 Oct 2026, Open access, CC BY, Preprint, not peer-reviewed
